A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced today that the Food and Drug ...

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial July 03, 2025 — 01:23 pm EDT Written by RTTNews.com for RTTNews -> ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

A new clinical trial using a botanical psilocybin drug to treat co-occurring PTSD and alcohol use disorder (AUD) in veterans ...

Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...

Earn Continuing Education credits and learn about the complex interplay between alcohol use disorder (AUD) and common ...

Approved for Alcohol Abuse in Austria and Italy The drug has also been suggested to reduce pain and improve function in fibromyalgia, but the EMA said the data were insufficient to support its use ...

The Drugs Consultative Committee (DCC) has agreed to amend the Drugs Rules, 1945 to regulate the alcohol content in tinctures ...

Generic Ablysinol is indicated for the induction of controlled cardiac septal infarction to improve exercise capacity in adult patients with hypertrophic obstructive cardiomyopathy.

When flibanserin was approved, it came with a boxed warning about hypotension and syncope in women taking the drug after drinking alcohol, which had been seen in the product's clinical trials.